top of page

DIANA BROWN AESTHETICS is committed to providing a transparent and safe experience for all clients.

DISCLAIMERS

Xeomin

New Zealand Mandatory Information for Customer use

Disclaimer: Xeomin ® (Incobotulinumtoxin A) 50, 100 Units is a Prescription Medicine. Indications: In adults, for the treatment of cervical dystonia; blepharospasm; spasticity of the upper limb; upper facial lines: glabellar frown lines, lateral periorbital lines (crow’s feet), horizontal forehead lines. Xeomin has both risks and benefits, consult your doctor if Xeomin is right for you. Further information on the  risks and benefits of Xeomin can be found in the Consumer Medicine Information (CMI) available from www.medsafe.govt.nz or by calling 0800 822 310. Use strictly as directed. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. Common side effects include: Headaches; nausea; tenderness, swelling, redness, numbness or bruising of the skin; dry eye; heavy feeling of eyelid/eyebrow/forehead; face/brow not symmetrical, dropping eyelids/eyebrows. Serious side effects are rare and include allergic reactions. Xeomin is an unfunded medicine, prescription charge will apply. Normal doctor charges will still apply. Copyright ©2023.Pharmacy Retailing NZ Limited t/a Health Care Logistics (HCL) 58 Richard PearseDrive, Mangere, Auckland 2022.All rights reserved. Xeomin® and Merz Aesthetics are registered trademarks of Merz Pharma GMbH & Co. KGaA.For information about how Merz handles personal data, please see Merz General Data ProtectionInformation Notice atwww.merz.com/fin

Sunekos

Sunekos containing hyaluronic acid and amino acids is a class III medical device that modifies the structure of mature skin, restoring volume, filling wrinkles and folds in the skin and in scar sites. Sunekos has risks and benefits.Sunekos should not be used on patients; with known hypersensitvity to any of its components; presenting with a general infection, inflammation or irritation in the area to be treated; or in patients predisposed to coagulation disorders. A local reaction may rarely occur, caused by hyper sensitisation phenomena, with symptoms that include oedema and sensation of burning and/or itching. These reactions normally resolve within two days. Consult your healthcare professional to see if Sunekos is right for you. For more information refer to the instructions for use. http://www.xytide.co.nz 

New Zealand sponsor: AA-Med Pty Ltd, Distributed by: Xytide Biotech NZ Pty Ltd.

PRIVACY POLICY

We are committed to protecting your privacy. We recognise that your personal information is confidential and we understand that it is important for you to know how we treat your personal information. We hold all personal information subject to the Privacy Act 1993 and the terms in this Privacy Policy as set out below.

​

This Privacy Policy applies to all personal information collected by us about you through its website. This is information you have provided to us.

​

  1. We may use this information for the following purposes:
    To respond to your correspondence;
    To inform you of, and provide you with, new and existing products or services offered by us
     

  2. You may choose to restrict the collection or use of your personal information in the following ways:

    • When you are asked to fill in our contact form, if you do not want us to email you for marketing purposes then do not click subscribe to our newsletter;

    • If you have previously agreed to us using your personal information for direct marketing purposes, you may change your mind at any time by writing to or emailing us or by looking for the box on the website that you can click to tell us you don’t want that information to be used for direct marketing purposes
       

  3. As required by the Privacy Act 1993, we follow strict procedures when storing and using the information you have provided.
     

  4. If you believe that any information we are holding on you is incorrect or incomplete, please write to or email us as soon as possible, at our address provided in our contact details. We will promptly correct any information found to be incorrect and update any incomplete information.
     

  5. If we change any part of our Privacy Policy we will post these changes on this page so that you are always aware of how we are treating your personal information.

bottom of page